Home > Result Summaries: Compounds > iboctadekin Result Summaries: iboctadekin GSKStudy ID Phase Title Summary (Download) ILI105618 phase 1 A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18 (SB-485232) Administered by Intravenous Infusion in Combinationwith Rituximab in Adult Patients with B Cell Non-Hodgkin'sLymphoma" (0 citation(s)) ILI108621 phase 1 A phase I, dose escalation study to assess the safety & biological activity of Interleukin 18 (SB-485232) administered by IV infusion in combination with pegylated liposomal doxorubicin (Doxil) in advanced stage epithelial ovarian cancer (0 citation(s))
